Superstring Capital Management »

Arvinas Ord shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Arvinas Ord (ARVN) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Arvinas Ord

Tip: Access up to 7 years of quarterly data

All positions including Arvinas Ord held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arvinas Ord by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 313k 10.60

More positions owned by Superstring Capital Management

Summit Therapeutics (SMMT)
Immunovant (IMVT)
Cogent Biosciences (COGT)
Savara (SVRA)
Urogen Pharma (URGN)
Definium Therapeutics Com Shs (DFTX)
Vir Biotechnology (VIR)
Vaxcyte (PCVX)
Celldex Therapeutics Com New (CLDX)
Sionna Therapeutics (SION)
Genmab A/s Sponsored Ads (GMAB)
Zai Lab Adr (ZLAB)
Vertex Pharmaceuticals Incorporated (VRTX)
Iqvia Holdings (IQV)
Maplight Therapeutics (MPLT)

View all positions for Superstring Capital Management

Top funds holding Arvinas Ord

BlackRock
Vanguard Portfolio Management
D. E. Shaw & Co
Pfizer
Vanguard Capital Management
TCG Crossover Management
Armistice Capital
Two Sigma Investments
State Street Corporation
Geode Capital Management
Jacobs Levy Equity Management
Citadel Advisors
Qube Research & Technologies
Federated Investors
Acadian Asset Management

View all funds holding Arvinas Ord